ASX-listed Zelira Therapeutics has announced the launch of its proprietary CBD toothpaste in the US in partnership with oral care company SprinJene.
The toothpaste is the first of several scientifically formulated, hemp-derived, oral care products containing cannabinoids, including broad-spectrum CBD, to be created and launched under the Zelira Oral Care subsidiary that has partnered with SprinJene.
Research shows that incorporating CBD into oral/dental care results in health benefits including naturally eliminating decay-causing bacteria, reducing gum inflammation, restoring pH balance and increasing remineralisation and reducing bone loss associated with gum disease.
The Zelira-SprinJene CBD toothpaste uses broad-spectrum, THC-free CBD distillate derived from hemp.
It will be distributed in the US through SprinJene’s existing distribution channels including retail stores and e-commerce platforms such as Amazon.
Discussions are ongoing to access SprinJene’s global distribution networks in France, Russia, UK, Singapore, Ukraine, China, Morocco, United Arab Emirates, Saudi Arabia and Sudan.